Sandacanol is a specific agonist of olfactory receptor (OR10H1). Sandacanol induces cell cycle arrest and some apoptosis in bladder cancer cells[1].
Sandacanol (50, 100, 300, 500, and 700 μM; 24 or 48 h) treatment significantly diminishes cell viability, cell proliferation and migration and induces a limited degree of apoptosis in BFTC905 bladder cancer cells[1].
[1]. Lea Weber, et al. Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer. Front Physiol. 2018 May 16;9:456.